A Prospective, Multi-center, Single-arm, Interventional Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant in China
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Antithymocyte globulin (Primary) ; Methylprednisolone; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Tacrolimus
- Indications Transplant rejection
- Focus Therapeutic Use
- Acronyms START-DCD
- Sponsors Sanofi; Sanofi (Beijing) Pharmaceuticals
- 12 Sep 2017 Planned End Date changed from 16 Aug 2019 to 31 Jul 2020.
- 12 Sep 2017 Planned primary completion date changed from 16 Aug 2019 to 31 Jul 2020.
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.